Simon May - Sep 1, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, President, LSG
Signature
/s/ Simon May
Stock symbol
BIO
Transactions as of
Sep 1, 2022
Transactions value $
-$62,726
Form type
4
Date filed
9/6/2022, 01:58 PM
Previous filing
Jan 7, 2022
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +371 +462.13% $0.00 451 Sep 1, 2022 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$62.7K -129 -28.59% $486.25 322 Sep 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +2.08K $0.00 2.08K Sep 1, 2022 Bio-Rad A Common Stock 2.08K $0.00 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -371 -24.97% $0.00 1.12K Sep 1, 2022 Bio-Rad A Common Stock 371 $0.00 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 24.0465 and 12.8145 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2022 and 06/30/2022, respectively.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2021, the reporting person was granted 1,486 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.